Study investigated the financial burden experienced from relapsing from certain leukemias and lymphomas.
Home / Resource Library / Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin Lymphoma